iLIFE ANTI-AGING CENTER
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- IV Therapy
- Laser Therapy (LLLT)
Houston, TX
Chelation therapy in Houston is offered by a small set of integrative and naturopathic clinics, typically for documented heavy metal toxicity. Referral and testing pathways often interact with Texas Medical Center, Memorial Hermann, Houston Methodist, and MD Anderson when lab confirmation is needed. Local demand is shaped by a large energy-industry and international patient base, and clinics vary in whether they push short detox courses or longer TACT-modeled cardiovascular protocols.
FDA-approved agents for specific poisoning diagnoses include calcium disodium EDTA, DMSA, and deferoxamine. Chelation for cardiovascular disease or autism is not FDA-approved and has caused deaths when the wrong EDTA form is used. Texas Medical Board and active compounding pharmacy ecosystem shapes which providers can deliver chelation and under what supervision.
With verified chelation clinics on Regenerated.com in Houston, Texas, patients can compare provider credentials, testing protocols, and whether the clinic uses calcium disodium EDTA (the correct form) or the dangerous disodium EDTA. ACAM-trained MDs with documented pre-treatment heavy metal testing are the minimum bar.
Regulatory context
The FDA has approved a narrow set of chelating agents for specific heavy metal toxicities. Calcium disodium edetate (CaNa2EDTA, Versenate) is approved for symptomatic lead poisoning, succimer (Chemet, DMSA) for pediatric lead poisoning at blood lead levels above 45 mcg/dL, deferoxamine (Desferal) and deferasirox (Exjade) for chronic iron overload, and dimercaprol (BAL) for arsenic, gold, and acute lead poisoning. Use of EDTA chelation for cardiovascular disease was studied in the NIH-funded TACT trial (2013) with controversial findings and remains not FDA-approved for that indication. Chelation for autism spectrum disorder is not evidence-based and has been linked to pediatric deaths. The FDA issued a 2010 sweep of warning letters to compounders marketing OTC chelation products with unapproved disease claims.
The Texas Medical Board has investigated chelation practitioners for marketing claims tied to autism and cardiovascular disease. Texas does not license NDs. Texas has a large integrative medicine community in Dallas, Houston, Austin, and San Antonio. The Texas Medical Board has historically been active in disciplining practitioners for off-label chelation marketing without adequate informed consent. The 2005 Pittsburgh pediatric chelation death informs Texas board expectations for pediatric protocols and use of the correct EDTA salt.